Apolipoprotein H levels in diabetic subjects: Correlation with cholesterol levels

被引:21
作者
Cassader, M
Ruiu, G
Gambino, R
Veglia, F
Pagano, G
机构
[1] HOSP S GIOVANNI BATTISTA,CENT LAB BALDI & RIBERI,TURIN,ITALY
[2] SCI INST HS RAFFAELE,EPIDEMIOL UNIT,MILAN,ITALY
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1997年 / 46卷 / 05期
关键词
D O I
10.1016/S0026-0495(97)90188-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To assess the relationship between apolipoprotein H (apo H) plasma levels and lipid metabolism in diabetes mellitus, we have examined the correlation between apa H plasma concentration and the main plasma lipid levels in 127 non-insulin-dependent (NIDDM) and 118 insulin-dependent (IDDM) diabetes mellitus patients. The data are compared with those in 286 nondiabetics. our data show a significant increase in plasma apo H in diabetic as opposed to nondiabetic subjects (NIDDM, 29.9 +/- 10.8 mg/dL; IDDM, 31.3 +/- 9.9; controls, 22.5 +/- 7.7; F = 53.3, P=.0001). The relation between plasma lipids and apo H was simultaneously evaluated in the three groups with inclusion of diabetes, sex, body mass index (IBM)), and age as covariates in the model. This analysis showed a strong positive correlation (P=.0009) between apo H and total cholesterol, and a weaker positive correlation with triglycerides ([TGs] P=.016]. The correlation between apo-H and hemoglobin A(1c) (HbA(1c)) levels in diabetics (P=.03) highlights the importance of glycemic control for plasma levels of this apoprotein, which is highly glycated. Although the role of apo H in lipid metabolism is still uncertain, recent investigations on the possible relation between plasma apo H levels and increased plasma lipids and thrombotic risk could explain the increased atherosclerotic risk in diabetic patients. Copyright (C) 1997 by W.B. Saunders Company .
引用
收藏
页码:522 / 525
页数:4
相关论文
共 29 条
[1]   INFLUENCE OF APOLIPOPROTEIN-H POLYMORPHISM ON LEVELS OF TRIGLYCERIDES [J].
CASSADER, M ;
RUIU, G ;
GAMBINO, R ;
GUZZON, F ;
PAGANO, A ;
VEGLIA, F ;
PAGNI, R ;
PAGANO, G .
ATHEROSCLEROSIS, 1994, 110 (01) :45-51
[2]   MOLECULAR-CLONING AND SEQUENCE-ANALYSIS OF THE CDNA-ENCODING HUMAN APOLIPOPROTEIN-H (BETA-2-GLYCOPROTEIN-I) [J].
DAY, JR ;
OHARA, PJ ;
GRANT, FJ ;
LOFTONDAY, C ;
BERKAW, MN ;
WERNER, P ;
ARNAUD, P .
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1992, 21 (03) :256-263
[3]   ANTICARDIOLIPIN ANTIBODIES (ACA) DIRECTED NOT TO CARDIOLIPIN BUT TO A PLASMA-PROTEIN COFACTOR [J].
GALLI, M ;
COMFURIUS, P ;
MAASSEN, C ;
HEMKER, HC ;
DEBAETS, MH ;
VANBREDAVRIESMAN, PJC ;
BARBUI, T ;
ZWAAL, RFA ;
BEVERS, EM .
LANCET, 1990, 335 (8705) :1544-1547
[4]  
Gambino R, 1996, J LIPID RES, V37, P902
[5]  
HENRY ML, 1988, J LAB CLIN MED, V111, P519
[6]  
HOWARD BV, 1987, J LIPID RES, V28, P613
[7]  
KAMBOH MI, 1991, ADV LIPID RES, V1, P9
[8]   BETA2-GLYCOPROTEIN-I [J].
KANDIAH, DA ;
KRILIS, SA .
LUPUS, 1994, 3 (04) :207-212
[9]   EFFECTS OF POLYMORPHISMS IN APOLIPOPROTEIN-E, APOLIPOPROTEIN-A-IV, AND APOLIPOPROTEIN-H ON QUANTITATIVE TRAITS RELATED TO RISK FOR CARDIOVASCULAR-DISEASE [J].
KAPRIO, J ;
FERRELL, RE ;
KOTTKE, BA ;
KAMBOH, MI ;
SING, CF .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (05) :1330-1348
[10]  
LEE NS, 1983, J BIOL CHEM, V258, P4765